Targeted deletion of Rac1 or inhibition of Rac1 activity by the chemical inhibitor NSC23766 in epidermal keratinocytes reduced skin tumor formation in a chemical skin carcinogenesis model [12, 15]. This evidence concerns the gene RAC1 and skin neoplasm.